All Posts

Q4 13F filings are now available.

Summary

Summary

The JP Morgan Healthcare Conference generates thousands of data points every year, including company presentations, slide decks, pipeline updates, guidance revisions, and strategic commentary.

The JP Morgan Healthcare Conference generates thousands of data points every year, including company presentations, slide decks, pipeline updates, guidance revisions, and strategic commentary. But while the volume of information is enormous, only a small subset of these updates actually change market-moving catalysts . In this post, we focus exclusively on Big Mover changes that were directly linked to JP Morgan 2026 presentations , filtering out routine updates, background c

After a difficult 3 years of private biotech funding for early-stage biotech companies (FN1, FN2), we predict that 2026 will be a breakout year. Why?

BPIQ has launched a new feature called High Management Interest , available exclusively to BPIQ APEX subscribers. High Management Interest is designed to help investors identify Big Movers and Suspected Movers  where company management has publicly signaled a high level of strategic focus or confidence  around an upcoming catalyst. What Is High Management Interest? High Management Interest  highlights companies with upcoming Big Mover or Suspected Mover catalysts  where manag

BPIQ has released its Big Movers list for Q1 2026 , giving investors a focused view of upcoming biotech events that have the potential to significantly impact the price of the underlying stock.

Hedge Fund Picks & Hedge Fund Avoids In addition to releasing the Q1 2026 Big Movers list, BPIQ has also launched new features  that show how biopharma-focused hedge funds  are positioned around these catalysts. Hedge Fund Picks Hedge Fund Picks are Big Mover™ catalysts) for biotech stocks with significant hedge fund ownership. These companies are actively held by a relatively large number of biopharma-focused hedge funds, helping you focus on high-conviction catalysts follow

The 44rd Annual J.P. Morgan Healthcare Conference is taking place in San Francisco, CA from January 12-15, 2026. "This premier conference is the largest and most informative healthcare investment symposium in the industry which connects global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community." ( https://www.jpmorgan.com/about-us/events-conferences/health-care-conference )